B
Bull
Bull · 25%GSRT
$13.70
情境價格
$15.520
+1.069 (+6.89%)收盤時
Loading chart…
- High
- 15.620
- Open
- 15.390
- VWAP
- 14.98
- Vol
- 2.74M
- Mkt Cap
- —
- Low
- 13.810
- Amount
- 41.10M
- EV/EBITDA, TTM
- 0.00
GSR III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not generated any revenue and has not commenced its business operations.
估值指標
The current forward P/E ratio for GSR III Acquisition Corp (GSRT) is -172.44, compared to its 5-year average forward P/E of -28.09.
Alphio AI Price Scenarios for GSRT
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding GSRT
事件時間軸
資訊
8.510-10Yahoo FinanceTerra Innovatum Global Finalizes Merger with GSR III Acquisition
8.510-07NewsfilterTerra Innovatum and GSR III Acquisition Corp. Confirm Shareholder Endorsement of Business Merger, Anticipating $130 Million in Total Proceeds Upon Completion
- 7.509-30Newsfilter
Terra Innovatum Forms Strategic Partnership with Defense Engineering Center, RAIT 88, to Speed Up Global Rollout of SOLO™ Micro-Modular Nuclear Reactors
- 7.509-29Newsfilter
TerraInnovatum and Ameresco Collaborate to Explore Public-Private Ventures for SOLO Micro-Modular Reactor Deployment in U.S. and Global Markets
8.509-15GlobenewswireTerra Innovatum and GSR III Acquisition Corp. Confirm S-4 Effectiveness and Schedule Extraordinary General Meeting to Approve Business Merger
GSRT FAQ — answered by Alphio AI
GSR III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not generated any revenue and has not commenced its business operations. It operates in the Financials sector.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。